$HQY

HEALTHEQUITY, INC. (HQY): Submission of Matters to a Vote of Security Holders

HEALTHEQUITY, INC. (HQY) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hqy-20260625 0001428336 false 0001428336 2026-06-25 2026-06-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) J

Original reporting
Published Jun 26, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$HQY
Neutral
medium confidence
Mentioned
$HQY
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HQYNeutralLow
01

Why it matters

Stockholders approved all five proposals, including election of ten directors, ratification of PwC as auditor, advisory say-on-pay, and approval of the 2026 Employee Stock Purchase Plan and the amended/restated 2024 Equity Incentive Plan.

02

Market read

This reduces uncertainty around governance and equity compensation approvals, but does not change near-term fundamentals in the text provided.

03

What to watch

If the equity incentive plan approvals affect share overhang expectations, the impact would show up only when paired with future dilution/compensation disclosures, not in this voting-results-only 8-K.

Relevance 6/10Novelty 3/10Timing: after-hours/filing of June 25, 2026 annual meeting voting results

Background

The company filed an SEC Form 8-K (Item 5.07) summarizing outcomes of its 2026 annual meeting held June 25, 2026.

Company-level read

Ticker impact

$HQYNeutralMedium confidence
Context

HealthEquity’s 8-K reports stockholder votes on five proposals at its June 25, 2026 annual meeting, including director elections and equity plan approvals.

Expected impact

Likely limited near-term impact; any reaction would be modest and mostly sentiment/governance-related.

Evidence & confidence

8-K Item 5.07 is a voting results disclosure. While it can remove uncertainty around equity plan approvals, it does not introduce new earnings, cash flow, or regulatory/contract catalysts.

Market effects

Minimal; governance/equity-plan vote outcomes are company-specific and not a sector-wide catalyst.

Minimal; no cross-regional macro or policy linkage is disclosed.

Minimal; no international transaction or global regulatory action is mentioned.

Counterpoint

Even with approvals passing, the vote results may already be anticipated; traders may discount the filing as routine and focus on upcoming earnings or guidance instead.

Key entities

  • HEALTHEQUITY, INC.

    NASDAQ-listed issuer; reported voting results for five annual meeting proposals via SEC 8-K Item 5.07.

  • PricewaterhouseCoopers LLP

    Ratified by stockholders as independent registered public accounting firm for fiscal year ending January 31, 2027.

Related articles

$HQYMed

HealthEquity rating upgraded by Moody’s on strong cash flow

Moody’s upgraded HealthEquity, Inc. (NASDAQ:HQY) corporate family rating to Ba2 from Ba3 and raised its probability of default rating to Ba2-PD from Ba3-PD. It also upgraded $600 million senior unsecured notes to Ba3 from B1, with outlook changed to stable. Moody’s cited stronger operating cash flow and BenefitWallet integration, plus improved leverage and liquidity.

$HQYMedAI 9/10

HealthEquity Q1 2027 Earnings Call: Complete Transcript - HealthEquity (NASDAQ: HQY)

HealthEquity reported fiscal 2027 first-quarter results, citing 7% year-over-year revenue growth and a record adjusted EBITDA margin of 46%, according to the company. It raised guidance to $1.41–$1.42B revenue and $625–$633M adjusted EBITDA. The firm said it expanded digital engagement and Marketplace, used AI for efficiency, saw HSA assets +19% and new HSA sales +15%, and increased its share repurchase authorization by $1B.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.